Ai Tran is a Nephrology physician affiliated with Albany College of Pharmacy and Health Sciences. OpenAlex indexes 11 publications with 325 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6909 Burlington Pike Ste B
Florence, KY 410421618
Telephone
859-912-7716Provider last certified this registry record 27 May 2020.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Calliditas Therapeutics US Inc.Program year20232 payments
- Novo Nordisk IncProgram year20231 payment
- Vifor Pharma, Inc.Program year20224 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
67.7%Calcium channel blocker14%Amlodipine Besylate67%Nifedipine Er33%Part D≥54 patientsLoop diuretic11.1%Furosemide66%Torsemide22%Bumetanide12%Part D<11 patients+ 9 more classes in this area
Metabolism & gastrointestinal
9.7%Vitamin D3 Analog4.3%Calcitriol100%Part D≥16 patientsPotassium supplement2.5%Potassium Chloride77%Klor-Con M2023%Part D<11 patients+ 3 more classes in this area
Musculoskeletal
8.6%Xanthine oxidase inhibitor8.6%Allopurinol100%Part D≥45 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Dual-Function Probes to Tag, Isolate and Identify Nucleobase-Binding Proteins
SSRN Electronic Journal
2023 - Retraction: Convenient synthesis of pyrimidine 2′-deoxyribonucleoside monophosphates with important epigenetic marks at the 5-position
Organic & Biomolecular Chemistry
2021 - Chemo-enzymatic synthesis of isotopically labeled nicotinamide riboside
Organic & Biomolecular Chemistry
2018
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”